46 related articles for article (PubMed ID: 1970716)
1. Advanced breast cancer: response to somatostatin.
Stolfi R; Parisi AM; Natoli C; Iacobelli S
Anticancer Res; 1990; 10(1):203-4. PubMed ID: 1970716
[TBL] [Abstract][Full Text] [Related]
2. Effect of the long-acting somatostatin analogue SMS 201-995 (Sandostatin) in advanced breast cancer.
Vennin P; Peyrat JP; Bonneterre J; Louchez MM; Harris AG; Demaille A
Anticancer Res; 1989; 9(1):153-5. PubMed ID: 2539768
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial on sms-D70 somatostatin analogue in advanced prostate and renal cell cancer.
Joensuu TK; Nilsson S; Holmberg AR; Márquez M; Tenhunen M; Saarto T; Joensuu H
Ann N Y Acad Sci; 2004 Dec; 1028():361-74. PubMed ID: 15650261
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy with vinorelbine, cisplatin and continuous infusion of 5-fluorouracil in locally advanced breast cancer: a promising low-toxic regimen.
Orlando L; Colleoni M; Curigliano G; Nolè F; Ferretti G; Masci G; Peruzzotti G; Minchella I; Intra M; Veronesi P; Viale G; Goldhirsch A
Anticancer Res; 2001; 21(6A):4135-9. PubMed ID: 11911307
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of a combination of vinorelbine, cyclophosphamide and 5-fluorouracil in the treatment of advanced breast cancer.
Ardavanis A; Extra JM; Espié M; Cuvier C; Marty M
In Vivo; 1998; 12(5):559-62. PubMed ID: 9827368
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.
O'Byrne KJ; Dobbs N; Propper DJ; Braybrooke JP; Koukourakis MI; Mitchell K; Woodhull J; Talbot DC; Schally AV; Harris AL
Br J Cancer; 1999 Mar; 79(9-10):1413-8. PubMed ID: 10188884
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
8. [Intra-arterial infusion chemotherapy with adriamycin for the treatment of locally advanced breast cancer--studies of serum and tissue concentrations of adriamycin].
Takatsuka Y; Imamotoh H; Tsuchiyama M; Numata N; Kawahara T
Gan To Kagaku Ryoho; 1982 May; 9(5):880-7. PubMed ID: 7184432
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies.
Schulz S; Schulz S; Schmitt J; Wiborny D; Schmidt H; Olbricht S; Weise W; Roessner A; Gramsch C; Höllt V
Clin Cancer Res; 1998 Sep; 4(9):2047-52. PubMed ID: 9748118
[TBL] [Abstract][Full Text] [Related]
10. The role of somatostatin analogues in complete antiandrogen treatment in patients with prostatic carcinoma.
Vainas G; Pasaitou V; Galaktidou G; Maris K; Christodoulou K; Constantinidis C; Kortsaris AH
J Exp Clin Cancer Res; 1997 Mar; 16(1):119-26. PubMed ID: 9148872
[TBL] [Abstract][Full Text] [Related]
11. Treatment of relapsing bleeding peptic ulcers with the somatostatin analogue SMS 201 995 in a patient with Zollinger-Ellison syndrome.
Wörmann B; Kutz K; Ottenjann R
Hepatogastroenterology; 1985 Jun; 32(3):152-3. PubMed ID: 2862099
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer.
Lück HJ; Thomssen C; du Bois A; Untch M; Lisboa B; Köhler G; Diergarten K
Semin Oncol; 1997 Oct; 24(5 Suppl 17):S17-35-S17-39. PubMed ID: 9374090
[TBL] [Abstract][Full Text] [Related]
13. [Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--second report].
Sakai K; Yayoi E; Terasawa T; Koyama H; Takatsuka Y; Inoue K; Tominaga T; Yoshida K; Kurokawa Y; Watanabe H
Gan To Kagaku Ryoho; 1983 Nov; 10(11):2301-8. PubMed ID: 6639092
[TBL] [Abstract][Full Text] [Related]
14. First-line intra-arterial chemotherapy (IAC) with epirubicin and mitoxantrone in locally advanced breast cancer.
Fiorentini G; Tsetis D; Bernardeschi P; Varveris C; Rossi S; Kalogeraki A; Athanasakis E; Dentico P; Kanellos P; Biancalani M; Almarashdah S; Zacharioudakis G; Saridaki Z; Chalkiadakis G; Xynos E; Zoras O
Anticancer Res; 2003; 23(5b):4339-45. PubMed ID: 14666649
[TBL] [Abstract][Full Text] [Related]
15. [Effect of intra-arterial infusion of adriamycin on locally advanced primary breast cancer--third report. Clinical Study Group of Adriamycin for Breast Cancer in Japan].
Yayoi E; Terasawa T; Koyama H; Sakai K; Kurokawa Y; Asaishi K; Morimoto T; Takashima S; Takatsuka Y; Yoshida K
Gan To Kagaku Ryoho; 1988 Jun; 15(6):1873-80. PubMed ID: 3382239
[TBL] [Abstract][Full Text] [Related]
16. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
Pieńkowski T; Jagiello-Gruszfeld A
Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
[TBL] [Abstract][Full Text] [Related]
17. Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.
Bellino R; Cortese P; Danese S; De Sanctis C; Durando A; Genta F; Grio R; Giardina G; Katsaros D; Massobrio M; Richiardi G; Vicelli R
Anticancer Res; 2000; 20(6C):4825-8. PubMed ID: 11205227
[TBL] [Abstract][Full Text] [Related]
18. Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer.
D'Andrea G; Fennelly D; Norton L; Baselga J; Gilewski T; Hudis C; Moynahan ME; Raptis G; Sklarin N; Surbone A; Theodoulou M; Templeton MA; Yao TJ; Seidman AD
Clin Cancer Res; 1999 Feb; 5(2):275-9. PubMed ID: 10037175
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.
Setyono-Han B; Henkelman MS; Foekens JA; Klijn GM
Cancer Res; 1987 Mar; 47(6):1566-70. PubMed ID: 2880660
[TBL] [Abstract][Full Text] [Related]
20. Combined chemotherapy and preoperative irradiation for locally advanced noninflammatory breast cancer: updated results in a series of 120 patients.
Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1062-73. PubMed ID: 15234040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
